Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation (SYK) P/B ratio
As of 16 October 2026, Stryker Corporation (SYK) trades at a P/B ratio of 4.7×. Over the past ten years it has ranged from 3.7× (March 2020) to 7.6× (September 2021); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 6.0× | (9.88%) |
| FY2024 | 6.6× | 9.93% |
| FY2023 | 6.0× | 8.00% |
| FY2022 | 5.6× | (17.37%) |
| FY2021 | 6.8× | (3.64%) |
| FY2020 | 7.0× | 14.71% |
| FY2019 | 6.1× | 22.64% |
| FY2018 | 5.0× | (15.52%) |
| FY2017 | 5.9× | 26.48% |
| FY2016 | 4.7× | 13.76% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 5.0× | (8.07%) |
| Mar 2026 | 5.5× | (8.62%) |
| Dec 2025 | 6.0× | (7.67%) |
| Sep 2025 | 6.5× | (9.06%) |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.8× |
| MDT Medtronic PLC compare | 2.4× |
| BSX Boston Scientific Corporation compare | 2.6× |
| GEHC GE HealthCare Technologies Inc. compare | 2.9× |
| STE STERIS plc compare | 3.0× |
| ABT Abbott Laboratories compare | 3.5× |
| EW Edwards Lifesciences Corporation compare | 4.7× |
| SYK Stryker Corporation | 4.7× |
| DXCM DexCom, Inc. compare | 12.5× |
| Medical Devices industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement